Literature DB >> 25343149

An antiemetic for irritable bowel syndrome?

Robert Levy1, Jason Corbo, Shailendra Prasad.   

Abstract

A drug used for cancer patients may provide some relief to patients with IBS.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25343149      PMCID： PMC4286118     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  15 in total

1.  Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom.

Authors:  B A Hahn; S Yan; S Strassels
Journal:  Digestion       Date:  1999 Jan-Feb       Impact factor: 3.216

Review 2.  Diagnostic evaluation of the irritable bowel syndrome.

Authors:  M M Schuster
Journal:  Gastroenterol Clin North Am       Date:  1991-06       Impact factor: 3.806

3.  A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome.

Authors:  Y A Saito; G R Locke; N J Talley; A R Zinsmeister; S L Fett; L J Melton
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

4.  The burden of selected digestive diseases in the United States.

Authors:  Robert S Sandler; James E Everhart; Mark Donowitz; Elizabeth Adams; Kelly Cronin; Clifford Goodman; Eric Gemmen; Shefali Shah; Aida Avdic; Robert Rubin
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

5.  Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.

Authors:  Kirsten Tillisch; Jennifer S Labus; Bruce D Naliboff; Roger Bolus; Michael Shetzline; Emeran A Mayer; Lin Chang
Journal:  Am J Gastroenterol       Date:  2005-04       Impact factor: 10.864

Review 6.  Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: a review.

Authors:  F A Luscombe
Journal:  Qual Life Res       Date:  2000-03       Impact factor: 4.147

7.  Irritable bowel syndrome in general practice: prevalence, characteristics, and referral.

Authors:  W G Thompson; K W Heaton; G T Smyth; C Smyth
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

Review 8.  Pharmacologic therapy for the irritable bowel syndrome.

Authors:  Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2003-04       Impact factor: 10.864

9.  Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?

Authors:  D G Maxton; J Morris; P J Whorwell
Journal:  Aliment Pharmacol Ther       Date:  1996-08       Impact factor: 8.171

10.  An office guide to whole-gut transit time. Patients' recollection of their stool form.

Authors:  K W Heaton; L J O'Donnell
Journal:  J Clin Gastroenterol       Date:  1994-07       Impact factor: 3.062
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.